| Vertex Pharmaceuticals Inc / Ma +1 co-filer10% owner · 6 transactions | — | 5.38Mas of Dec 2018 | — | 130.9K | — |
| Bolzon Bradley J PhDDirector · 228 transactions | — | 5.25M†as of Jul 2021 | 60.0K | 161.0K | 1.30M |
| Versant Affiliates Fund V, L.P. +8 co-filers10% owner · 12 transactions | — | 4.90M†as of Sep 2017 | — | — | — |
| Emster Kurt VonDirector · 46 transactions | — | 4.88M†as of Dec 2018 | — | 121.9K | 1.42M |
| Woiwode ThomasDirector · 70 transactions | — | 4.77M†as of May 2018 | — | 161.0K | 548.0K |
| Celgene Corp /De/10% owner · 23 transactions | — | 4.17Mas of Nov 2018 | — | 800.1K | 1.11M |
| Versant Affiliates Fund V, L.P. +6 co-filers10% owner · 8 transactions | — | 4.10M†as of Apr 2018 | — | — | 102.0K |
| Versant Affiliates Fund V, L.P. +5 co-filers10% owner · 18 transactions | — | 4.02M†as of Oct 2016 | — | 161.0K | — |
| Glaxosmithkline PLC10% owner · 3 transactions | — | 2.94Mas of Oct 2016 | — | 66.5K | — |
| George SimeonDirector · 9 transactions | — | 2.04M†as of Jul 2025 | 1.05M | 1.06M | — |
| Versant Affiliates Fund V, L.P. +4 co-filers10% owner · 4 transactions | — | 1.73M†as of Apr 2018 | — | — | 22.8K |
| Lundberg Sven AnteChief Scientific Officer · 2 transactions | — | 1.07M†as of Oct 2016 | — | 400 | — |
| Hadley Harbor Master Investors (Cayman) L.P.10% owner · 1 transaction | — | 744.4Kas of Oct 2016 | — | — | — |
| Novak RodgerPresident, Director · 84 transactions | — | 573.0Kas of Jun 2021 | 535.9K | — | 1.18M |
| Kulkarni SamarthChief Executive Officer, Director · 202 transactions | — | 341.1K† | 1.36M | — | 998.0K |
| Coles N AnthonyDirector · 2 transactions | — | 140.0K†as of Oct 2016 | 70.0K | — | — |
| Kasinger James R.General Counsel and Secretary · 54 transactions | — | 94.3K | 179.8K | — | 65.8K |
| Bayer Aktiengesellschaft +1 co-filer10% owner · 1 transaction | — | 75.9Kas of Jan 2018 | — | 527.5K | — |
| Ho Tony WExecutive VP, Head of R&D · 27 transactions | — | 52.4Kas of Dec 2021 | 146.5K | — | 37.4K |
| Bruno JulianneChief Operating Officer · 10 transactions | — | 27.8K†as of Mar 2025 | 14.2K | — | 6.8K |
| Klein Lawrence OttoCBO & COO · 39 transactions | — | 26.8Kas of Mar 2022 | 288.2K | — | 215.0K |
| Dylan-Hyde TylerChief Legal Officer · 31 transactions | — | 25.2Kas of Jan 2018 | 45.0K | — | 225.0K |
| Treco Douglas ADirector · 1 transaction | — | 22.0Kas of Aug 2025 | — | 20.0K | — |
| Patel NaimishChief Medical Officer · 7 transactions | — | 19.4K | 28.1K | 1.5K | 10.9K |
| Prasad RajuChief Financial Officer · 23 transactions | — | 15.6K | 114.0K | — | 97.7K |
| Greene JohnDirector · 1 transaction | — | 7.0Kas of Feb 2025 | — | 7.0K | — |
| Smith BrendanChief Financial Officer · 4 transactions | — | 5.1Kas of Feb 2023 | 7.6K | — | — |
| Morrow Phuong KhanhChief Medical Officer · 2 transactions | — | 4.4Kas of May 2023 | 6.9K | — | — |
| Tomsicek Michael JohnChief Financial Officer · 12 transactions | — | 1.9Kas of Aug 2021 | 51.8K | — | 49.0K |
| Behbahani AliDirector · 3 transactions | — | 270†as of Aug 2020 | — | — | — |
| Cagnoni Pablo JDirector · 10 transactions | — | 0as of Nov 2019 | 30.0K | — | 30.0K |